Bliss GVS Pharma Limited: board meetings

61 records, the earliest from 11 Nov 2010. As filed with the exchanges; the history is only as deep as the data Tradinity has collected.

61 shown.

Sign in to see more, or upgrade your plan to see the full history. Sign in

DatePurposeNotes
1 Oct 2026Fund Raising/Other business mattersTo consider Fund Raising and other business matters
12 Aug 2026Financial Results/Other business mattersPlease find enclosed herewith intimation regarding pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday, August 12, 2026, at the registered office of the Company to consider and approve, inter alia, the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026.
12 May 2026Financial Results/Dividend/Other business mattersTo consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
10 Feb 2026Financial Results/DividendTo consider and approve the Unaudited financial results for the period ended December 31, 2025 and the interim dividend, if any, for the financial year 2025-2026
6 Nov 2025Financial ResultsTo consider and approve the Unaudited Standalone and Consolidated financial results for the quarter and half year ended September 30, 2025
29 Jul 2025Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2025
12 May 2025Other business mattersIntimation of Board Meeting to consider Issuance of Sweat Equity Shares.
12 May 2025Financial Results/DividendTo consider and approve the financial results for the period ended March 31, 2025 and dividend
28 Jan 2025Financial Results/Other business mattersInter alia to consider, approve and take on record: 1. The Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2024; and2. The proposal for issuance of Sweat Equity Shares pursuant to applicable provisions of the Companies Act, 2013, the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 and other applicable laws and regulations to Key Managerial Personnel and/or Senior Management Personnel and/or Employee(s) of the Company including determination of the issue price if any, subject to such regulatory and statutory approvals as may be required including approval of the shareholders of the Company.
24 Oct 2024Financial Results/Other business mattersTo consider and approve the financial results for the period ended September 30, 2024 and other business matters

Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.